| Tengion Announces Addition of Two Renal Experts to Research Development ... - PR-USA.net (press release) |
|
|
PR-USA.net (press release) Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced the addition of two renal research and clinical experts, Ben Humphreys, MD, Ph.D. and Giuseppe Remuzzi, MD, FRCP, from the Harvard Stem Cell Institute and Mario Negri |